Pooled analysis of two phase III studies provides prognostic indicators for clinical outcome after catumaxomab treatment for malignant ascites

被引：0
|
作者：
Bokemeyer, C. [1 ]
Heiss, M. M. [2 ]
Lordick, F. [3 ]
Parsons, S. L. [4 ]
Wimberger, P. [5 ]
Friccius-Quecke, H. [6 ]
机构：
[1] Univ Klinikum Hamburg Eppendorf, Hamburg, Germany
[2] Univ Witten Herdecke, Krankenhaus Koln Merheim, Cologne, Germany
[3] Univ Klinikum, Leipzig, Germany
[4] Nottingham Univ Hosp NHS Trust, Nottingham, England
[5] Tech Univ Dresden, D-01062 Dresden, Germany
[6] Fresenius Biotech GmbH, Munich, Germany
来源：
ONKOLOGIE | 2013年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：273 / 274
页数：2
相关论文
共 50 条
  • [31] Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 Studies
    Peter Nash
    Laura C. Coates
    Roy Fleischmann
    Kim A. Papp
    Juan Jesus Gomez-Reino
    Keith S. Kanik
    Cunshan Wang
    Joseph Wu
    Sujatha Menon
    Thijs Hendrikx
    William C. Ports
    Rheumatology and Therapy, 2018, 5 : 567 - 582
  • [32] Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 Studies
    Nash, Peter
    Coates, Laura C.
    Fleischmann, Roy
    Papp, Kim A.
    Jesus Gomez-Reino, Juan
    Kanik, Keith S.
    Wang, Cunshan
    Wu, Joseph
    Menon, Sujatha
    Hendrikx, Thijs
    Ports, William C.
    RHEUMATOLOGY AND THERAPY, 2018, 5 (02) : 567 - 582
  • [33] Efficacy and clinical relevance of vilazodone in the treatment of major depressive disorder: a pooled analysis of phase III clinical trials
    Khan, A.
    Song, W.
    Edwards, J.
    Ruth, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S253 - S254
  • [34] Efficacy and clinical relevance of vilazodone in the treatment of major depressive disorder : A pooled analysis of phase III clinical trials
    Khan, A.
    Song, W.
    Ruth, A.
    Edwards, J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 186 - 187
  • [35] EFFICACY AND CLINICAL RELEVANCE OF VILAZODONE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER: A POOLED ANALYSIS OF PHASE III CLINICAL TRIALS
    Culpepper, Larry
    Khan, Arif
    Ruth, Adam
    Edwards, John
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2013, 28 : S71 - S72
  • [36] Safety and Efficacy of Mirogabalin for Peripheral Neuropathic Pain: Pooled Analysis of Two Pivotal Phase III Studies
    Kato, Jitsu
    Baba, Masayuki
    Kuroha, Masanori
    Kakehi, Yoshihiro
    Murayama, Emiko
    Wasaki, Yosuke
    Ohwada, Shoichi
    CLINICAL THERAPEUTICS, 2021, 43 (05) : 822 - +
  • [37] Maintenance of quality of life (QoL) and general health state in patients with malignant ascites during treatment with the trifunctional antibody catumaxomab: results from the phase III b CASIMAS trial
    Lordick, F.
    Sehouli, J.
    Vergote, I
    Rosenberg, P.
    Schneeweiss, A.
    Block, A.
    Salat, C.
    Scambia, G.
    Berton-Rigaud, D.
    Siena, S.
    Santoro, A.
    Cervantes-Ruiperez, A.
    Guastalla, J. P.
    Tournigand, C.
    Colombo, N.
    Dudnitchenko, A. S.
    Bondar, V
    Westermann, A. M.
    Wimberger, P.
    ONKOLOGIE, 2012, 35 : 62 - 63
  • [38] Cardiovascular safety of liraglutide: a pooled analysis from phase II and III liraglutide clinical development studies
    Huang, Y. Y.
    Marso, S. P.
    Moses, A. C.
    Zychma, M. J.
    Buse, J. B.
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2012, 28 : 91 - 91
  • [39] Cardiovascular Safety of Liraglutide: A Pooled Analysis from Phase II and III Liraglutide Clinical Development Studies
    Marso, Steven P.
    Moses, Alan C.
    Zychma, Marcin J.
    Buse, John B.
    CIRCULATION, 2010, 122 (21)
  • [40] Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: pooled analysis of two phase III, randomized, double-blind studies
    Papp, K.
    Szepietowski, J. C.
    Kircik, L.
    Toth, D.
    Kuligowski, M. E.
    Venturanza, M. E.
    Sun, K.
    Simpson, E. L.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (03) : E62 - E63
12345